Page last updated: 2024-12-07

3-deoxyglycero-galacto-nonulosonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-deoxyglycero-galacto-nonulosonic acid: deaminated neuraminic acid from rainbow trout; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID123691
CHEBI ID176465
SCHEMBL ID15121303
MeSH IDM0143046

Synonyms (20)

Synonym
siax
3-deoxyglycero-galacto-nonulosonic acid
unii-9672k4u8iw
deoxy-kdn
3-deoxyglycerogalacto-2-nonulopyranosonic acid
2-kdn
9672k4u8iw ,
2-oxo-3-deoxy-d-glycero-galactononulosonic acid
d-glycero-d-galacto-2-nonulosonic acid, 3-deoxy-
(4s,5r,6r,7r,8r)-4,5,6,7,8,9-hexahydroxy-2-oxononanoic acid
CHEBI:176465
22594-61-2
sialosonic acid
3-deoxy-d-glycero-d-galacto-nonulosonic acid
112543-66-5
SCHEMBL15121303
3-deoxy-d-glycero-d-galacto-2-*nonulosonic acid a
Q27896051
4,5,6,7,8,9-hexahydroxy-2-oxo-nonanoic acid
DTXSID201247051
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
L-alpha-D-Hepp-(1->7)-L-alpha-D-Hepp-(1->3)-L-alpha-D-Hepp-(1->5)-alpha-KdoA linear tetrasaccharide comprising three L-glycero-alpha-D-manno-heptose residues and a 3-deoxy-alpha-D-manno-oct-2-ulosonic acid (2-keto-3-deoxy-alpha-D-mannooctanoic acid, alpha-Kdo) residue in a (1->7), (1->3), (1->5) sequence.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (61)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (8.20)18.7374
1990's29 (47.54)18.2507
2000's17 (27.87)29.6817
2010's8 (13.11)24.3611
2020's2 (3.28)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.87 (24.57)
Research Supply Index4.14 (2.92)
Research Growth Index5.01 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (8.06%)6.00%
Case Studies1 (1.61%)4.05%
Observational0 (0.00%)0.25%
Other56 (90.32%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]